Al Shahrani M: Difference between revisions
From Bioblast
Nirschl Lisa (talk | contribs) No edit summary |
Nirschl Lisa (talk | contribs) No edit summary |
||
Line 13: | Line 13: | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at == | == Participated at == | ||
::::*[[IOC101| IOC101 London UK]] | |||
::::* [[IOC100| IOC100 Schroecken AT]] | ::::* [[IOC100| IOC100 Schroecken AT]] |
Latest revision as of 10:49, 26 April 2018
Name | Al Shahrani Mesfer, |
---|---|
Institution | The National Hospital for Neurology & Neurosurgery
Neurometabolic Unit |
Address | Queen Square, WC1N 3BG |
City | London |
State/Province | |
Country | United Kingdom |
[email protected] | |
Weblink | |
O2k-Network Lab | UK London Land JM |
Labels:
Publications
Published | Reference | |
---|---|---|
Hargreaves 2016 Drug Saf | 2016 | Hargreaves IP, Al Shahrani M, Wainwright L, Heales SJR (2016) Drug-induced mitochondrial toxicity. Drug Saf 39:661–74. https://doi.org/10.1007/s40264-016-0417-x. |